Compile Data Set for Download or QSAR
Report error Found 543 of affinity data for UniProtKB/TrEMBL: P07738
TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632630(US20230348450, Example 3)
Affinity DataEC50:  0.320nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632632(US20230348450, Example 209 | US20230348450, Exampl...)
Affinity DataEC50:  0.0680nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632633(US20230348450, Example 6)
Affinity DataEC50:  0.110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632634(US20230348450, Example 7)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632635(US20230348450, Example 8)
Affinity DataEC50:  0.0600nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632636(US20230348450, Example 9)
Affinity DataEC50:  0.460nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632637(US20230348450, Example 10)
Affinity DataEC50:  0.175nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632630(US20230348450, Example 3)
Affinity DataEC50:  320nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632631(US20230348450, Example 4)
Affinity DataEC50:  180nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632632(US20230348450, Example 209 | US20230348450, Exampl...)
Affinity DataEC50:  57nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632633(US20230348450, Example 6)
Affinity DataEC50:  110nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632634(US20230348450, Example 7)
Affinity DataEC50:  60nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632635(US20230348450, Example 8)
Affinity DataEC50:  60nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632636(US20230348450, Example 9)
Affinity DataEC50:  460nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632731(US20230348450, Example 113)
Affinity DataEC50:  170nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632732(US20230348450, Example 114)
Affinity DataEC50:  170nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632733(US20230348450, Example 115)
Affinity DataEC50:  180nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632734(US20230348450, Example 116)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632735(US20230348450, Example 117)
Affinity DataEC50:  8.70E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632736(US20230348450, Example 118)
Affinity DataEC50:  130nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632737(US20230348450, Example 119)
Affinity DataEC50:  1.80E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632738(US20230348450, Example 120)
Affinity DataEC50: >2.50E+4nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632739(US20230348450, Example 121)
Affinity DataEC50:  3.20E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632741(US20230348450, Example 123)
Affinity DataEC50:  9.70E+3nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632742(US20230348450, Example 124)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632743(US20230348450, Example 125)
Affinity DataEC50:  340nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632744(US20230348450, Example 126)
Affinity DataEC50:  240nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632745(US20230348450, Example 127)
Affinity DataEC50:  420nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632746(US20230348450, Example 128)
Affinity DataEC50:  79nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632747(US20230348450, Example 129)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632748(US20230348450, Example 130)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632749(US20230348450, Example 131)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632750(US20230348450, Example 132)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632751(US20230348450, Example 133)
Affinity DataEC50:  80nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632752(US20230348450, Example 134)
Affinity DataEC50:  340nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632753(US20230348450, Example 135)
Affinity DataEC50:  70nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632754(US20230348450, Example 136)
Affinity DataEC50:  90nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632755(US20230348450, Example 137)
Affinity DataEC50:  20nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632756(US20230348450, Example 139)
Affinity DataEC50:  90nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632757(US20230348450, Example 140)
Affinity DataEC50:  30nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632758(US20230348450, Example 141)
Affinity DataEC50:  70nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632759(US20230348450, Example 142)
Affinity DataEC50:  130nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632760(US20230348450, Example 143)
Affinity DataEC50:  80nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632762(US20230348450, Example 145)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632763(US20230348450, Example 146)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632764(US20230348450, Example 147)
Affinity DataEC50:  50nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632765(US20230348450, Example 148)
Affinity DataEC50:  280nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632766(US20230348450, Example 149)
Affinity DataEC50:  70nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632768(US20230348450, Example 151)
Affinity DataEC50:  70nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

TargetBisphosphoglycerate mutase(Human)
Genzyme

US Patent
LigandPNGBDBM632769(US20230348450, Example 152)
Affinity DataEC50:  40nMAssay Description:The following materials were used in this assay: Tris buffer (50 mM Tris, 0.01% Tween 20, pH 7.4); cyclohexylammonium salt of 2,3-BPG (stock solution...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 543 total ) | Next | Last >>
Jump to: